Fibristal recall in Canada: risk of serious liver injury
In plain language
This recall involves the drug Fibristal (ulipristal acetate) sold in Canada. It's being recalled because it may cause serious liver injury. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Report any signs of liver injury to your healthcare provider.
- Contact your doctor to discuss other treatment options.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Fibristal (ulipristal acetate)
Why this matters
Risk of serious liver injury
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of serious liver injury
What should consumers do?
Stop using the product immediately. Report any signs of liver injury to your healthcare provider. Contact your doctor to discuss other treatment options.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of serious liver injury
When was this product recalled?
This product was recalled on September 30, 2020.
Is the Fibristal brand affected by this recall?
Yes, Fibristal products are affected by this recall. This recall involves the drug Fibristal (ulipristal acetate) sold in Canada. It's being recalled because it may cause serious liver injury. Stop using the product and follow the return/repair steps in the official notice.